Name: Latest research reports of Dr. Agarwals Health Care Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Dr. Agarwals Health Care Ltd.
Rating: 5
Author: Motilal Oswal

Dr. Agarwals Health Care Ltd.

NSE: AGARWALEYE | BSE: 544350 | ISIN: INE943P01029 | Industry: Healthcare Facilities
| Expensive Underperformer

411.7500 4.40 (1.08%)

NSE Jul 03, 2025 15:31 PM

25.92% Gain from 52W Low

Volume: 289.3K

Dr. Agarwals Health Care Ltd.

29 May 2025

411.75

1.08%

Ends FY25 on strong operational performance

Buy: Dr. Agarwals Health Care Ltd.

Target

Motilal Oswal

Dr. Agarwal’s Health Care (DAHL) delivered in-line Revenue/EBITDA for the quarter. However, there was a miss on earnings due to higher-thanexpected interest outgo for the quarter.

Dr. Agarwals Health Care Ltd. is trading above all available SMAs